Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,828 | 444 | 99.6% |
| Education | $38.86 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,579 | 57 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,376 | 52 | $0 (2020) |
| PFIZER INC. | $1,237 | 58 | $0 (2020) |
| Lilly USA, LLC | $1,034 | 51 | $0 (2020) |
| GlaxoSmithKline, LLC. | $924.55 | 45 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $738.56 | 40 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $471.26 | 16 | $0 (2019) |
| AbbVie Inc. | $406.30 | 22 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $280.79 | 8 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $238.63 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $24.33 | 2 | AbbVie Inc. ($24.33) |
| 2020 | $559.54 | 27 | Lilly USA, LLC ($149.06) |
| 2019 | $3,756 | 173 | AstraZeneca Pharmaceuticals LP ($524.79) |
| 2018 | $2,675 | 126 | Novo Nordisk Inc ($677.73) |
| 2017 | $2,852 | 122 | PFIZER INC. ($421.89) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Central Nervous System | ||||||
| 08/21/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Central Nervous System | ||||||
| 05/06/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Diabetes | ||||||
| 03/09/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/05/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Neuroscience | ||||||
| 03/04/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/02/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Diabetes | ||||||
| 02/28/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/27/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $96.63 | General |
| Category: Diabetes | ||||||
| 02/25/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $90.00 | General |
| 02/24/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 02/24/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 02/24/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $5.40 | General |
| 02/20/2020 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
| 02/18/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: Diabetes | ||||||
| 02/11/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.81 | General |
| Category: Opioid Analgesic | ||||||
| 02/11/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 9 | 247 | 286 | $43,817 | $13,540 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 113 | $26,530 | $6,892 | 26.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 53 | 61 | $9,455 | $2,782 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 12 | 12 | $2,040 | $1,489 | 73.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 18 | $2,790 | $1,099 | 39.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $935.00 | $670.78 | 71.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 19 | $760.00 | $340.18 | 44.8% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 16 | 16 | $632.16 | $159.37 | 25.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 20 | 21 | $420.00 | $59.46 | 14.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 13 | 15 | $255.00 | $48.15 | 18.9% |
About Dr. Pramod Lele, MD
Dr. Pramod Lele, MD is a Internal Medicine healthcare provider based in Woodlyn, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114996634.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pramod Lele, MD has received a total of $9,866 in payments from pharmaceutical and medical device companies, with $24.33 received in 2021. These payments were reported across 450 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($9,828).
As a Medicare-enrolled provider, Lele has provided services to 247 Medicare beneficiaries, totaling 286 services with total Medicare billing of $13,540. Data is available for 1 year (2020–2020), covering 9 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Woodlyn, PA
- Active Since 03/16/2006
- Last Updated 07/10/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114996634
Products in Payments
- TRULICITY (Drug) $756.53
- Ozempic (Drug) $695.93
- FARXIGA (Drug) $695.89
- ELIQUIS (Drug) $514.01
- Victoza (Drug) $377.74
- INVOKANA (Drug) $374.55
- Tresiba (Drug) $373.99
- EUCRISA (Drug) $371.72
- XARELTO (Drug) $356.70
- TRELEGY ELLIPTA (Drug) $319.30
- Creon (Drug) $289.19
- ANORO (Drug) $269.11
- Vascepa (Drug) $236.17
- BYDUREON (Drug) $233.41
- JARDIANCE (Drug) $231.22
- LYRICA (Drug) $228.37
- ENTRESTO (Drug) $221.61
- CHANTIX (Drug) $188.17
- LOKELMA (Drug) $170.10
- SOLIQUA 100/33 (Drug) $159.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.